Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
To the Editor.— A workshop on human bone-marrow transplantation was held at the University of California at Davis on Dec 1, 1971. Attending were those scientists largely responsible for the 133 bone-marrow transplant attempts in 119 patients which have been reported to the American College of Surgeons/National Institutes of Health (ACS/NIH) BoneMarrow Transplant Registry. Complete or partial immunological reconstitution of children with a variety of immunological deficiency diseases was reported. In addition, several cases of successful allogenic bone-marrow grafts were cited in patients with aplastic anemia who had been refractory to previous therapies. Prior to allogenic bone-marrow transplantation, the patients with aplastic anemia received intensive immunosuppressive therapy utilizing antilymphocyte globulin or cyclophosphamide in order to prevent graft rejection. The subsequent demonstration of normal immunological or hematopoietic function plus a donor immunological or hematopoietic marker (eg, a change to donor serum immunoglobulin allotype, donor hematopoietic or lymphoid karyotype, or a change
JAMA – American Medical Association
Published: Jul 31, 1972
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.